Ventana Medical Systems' (Ventana) CONFIRM anti-EMA (E29) Mouse Monoclonal Primary Antibody (CONFIRM anti-EMA (E29)) is directed against epithelial membrane antigen expressed on the apical surface of glandular epithelia. This glycoprotein is primarily membrane localized on normal and tumor tissue, although it may exhibit a cytoplasmic localization in less differentiated carcinomas. This antibody may be used to aid in the identification of epithelial membrane antigen in adenocarcinomas derived from secretory epithelia, malignant mesothelioma, renal cell carcinomas and meningiomas. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue.
This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information and proper controls.
This antibody is intended for in vitro diagnostic (IVD) use.